Your browser doesn't support javascript.
loading
Liver gene transfer for metabolite detoxification in inherited metabolic diseases.
D'Alessio, Alfonso M; Boffa, Iolanda; De Stefano, Lucia; Soria, Leandro R; Brunetti-Pierri, Nicola.
Afiliação
  • D'Alessio AM; Telethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, Italy.
  • Boffa I; Scuola Superiore Meridionale (SSM, School of Advanced Studies), Genomics and Experimental Medicine Program, University of Naples Federico II, Naples, Italy.
  • De Stefano L; Telethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, Italy.
  • Soria LR; Azienda Ospedaliera Universitaria Federico II, Naples, Italy.
  • Brunetti-Pierri N; Telethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, Italy.
FEBS Lett ; 2024 Jun 17.
Article em En | MEDLINE | ID: mdl-38884367
ABSTRACT
Inherited metabolic disorders (IMDs) are a growing group of genetic diseases caused by defects in enzymes that mediate cellular metabolism, often resulting in the accumulation of toxic substrates. The liver is a highly metabolically active organ that hosts several thousands of chemical reactions. As such, it is an organ frequently affected in IMDs. In this article, we review current approaches for liver-directed gene-based therapy aimed at metabolite detoxification in a variety of IMDs. Moreover, we discuss current unresolved challenges in gene-based therapies for IMDs.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: FEBS Lett Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: FEBS Lett Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Itália